ArticleLife (Basel, Switzerland)2026
The Radiobiological Effect of Flattening Filter Free (FFF) Beam Delivery Parameters on A549 and MCF-7 Cell Survival: An In Vitro Study.
Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent improvements, such as flattening filter-free (FFF) beams, enable the delivery of treatments at higher dose rates and in shorter times. However, the biological influence still remains uncertain. Here, we examined how dose rate and dose per pulse influence responses to FFF beams compared with flattened beams in cancer cells with different radiosensitivities.
methodsA549 (lung, high α/β) and MCF-7 (breast, low α/β) cells were irradiated using VMAT (6 MV FF, 6 and 10 MV FFF; 600-2400 MU/min; 5-20 Gy). Cell viability was assessed by the WST-1 assay, and reproductive survival by clonogenic assay.
resultsThe responses differed by cell type and dose, with A549 exhibiting restricted sensitivity, demonstrating more pronounced effects at 10 Gy, while MCF-7 displayed greater responsiveness at 5-10 Gy under elevated dose rates. At 20 Gy, differences were reduced. Metabolic readouts did not consistently match clonogenic survival. Conclusions
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.